Skip to content
About LineaRx
Leadership Team
Investor Info
LinearDNA Platform
Biotherapeutic Applications
News
Resources
Let’s Connect
About
About LineaRx
Leadership Team
Investor Info
Platform
Applications
News
Resources
Let’s Connect
LineaRx Receives Repeat Orders for LinearDNA
November 15, 2021
Read More
email
LineaRx Receives Multiple Orders for Linear DNA for Use in Therapeutic Development
July 1, 2019
Read More
email
LineaRx Achieves Anti-CD19 Expression in Human CAR T Cells via Plasmid-Free Platform
April 8, 2019
Read More
email
APDN Forms Subsidiary, LineaRx, to Develop DNA for Biotherapeutics
September 18, 2018
Read More
email
Recent Press Releases
Applied DNA Enters into Agreement with Alphazyme for Scale-Up Manufacturing of its Proprietary Linea™ RNAP, Progresses Towards GMP Linea™ IVT Production Start
Applied DNA to Showcase Linea™ DNA and Linea™ IVT Platforms
Applied DNA Announces Joint Development Agreement to Integrate Linea™ IVT Platform into CDMO Kudo Biotechnology’s mRNA Manufacturing Workflow
APDN Announces Receipt of Linea™ DNA Follow-On Order for Cancer Diagnostic Application
Applied DNA Extends Application of Linea™ IVT Platform to saRNA (self-amplifying mRNA)
Applied DNA Ships First saRNA (self-amplifying mRNA) IVT Template Generated by Linea™ DNA Platform
APDN Partners with Cornell University College of Veterinary Medicine to Accelerate Development of Veterinary Vaccine Platform Targeting Diseases that Impact High-Value Animals
APDN Advances Commercialization of Linea™ IVT Platform, Appoints Beverly Wolgast as Executive Director of Quality and cGMP Programs
LineaRx to Participate in Upcoming mRNA Industry Conferences
APDN Acquires RNA Polymerase Developer Spindle Biotech, Launches LineaIVT™ Platform to Substantially Improve mRNA Manufacturing and Broaden Market Reach
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
Ok
